ChromaDex
CDXC
#6854
Rank
A$0.88 B
Marketcap
A$11.42
Share price
-0.88%
Change (1 day)
62.43%
Change (1 year)

Earnings for ChromaDex (CDXC)

Earnings in 2024 (TTM): A$13.97 Million

According to ChromaDex's latest financial reports the company's current earnings are A$99.59 Million. , an increase over its 2023 earnings that were of -A$7.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ChromaDex from 2007 to 2024

Annual earnings

Year Earnings Change
2024 A$12.84 M-279.32%
2023 -A$7.17 Million-70.15%
2022 -A$24.01 Million-39.03%
2021 -A$39.37 Million36.15%
2020 -A$28.92 Million-38.02%
2019 -A$46.65 Million-3.51%
2018 -A$48.35 Million101.55%
2017 -A$23.99 Million470.57%
2016 -A$4.21 Million4.72%
2015 -A$4.02 Million-48.66%
2014 -A$7.82 Million21.92%
2013 -A$6.42 Million-62.08%
2012 -A$16.92 Million48.18%
2011 -A$11.42 Million289.87%
2010 -A$2.93 Million125.95%
2009 -A$1.3 Million-54.35%
2008 -A$2.84 Million8290.97%
2007 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sangamo Therapeutics
SGMO
-A$0.16 Billion-1,331.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.36 B 10,529.09%๐Ÿ‡บ๐Ÿ‡ธ USA